Imatinib mesylate does not impair the immunogenicity of human myeloid blood dendritic cells.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/CF3C8ECB.svg?ark=w1%2F20260515%2FCF3C8ECB)](https://nobleid.org/work/w1/20260515/CF3C8ECB)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors